Veracyte in the news
September 14, 2024
Gerhard Attard, MD, on the interaction between Decipher score and docetaxel benefit
Urology Times
September 14, 2024
Veracyte’s CEO talks about ESMO data from it’s prostate cancer diagnostic that could change how metatstatic prostate cancer is treated
BiotechTV
August 6, 2024
Veracyte Q2 Revenues up 27 Percent on Prostate, Thyroid Tests; Firm Raises Full-Year Guidance
GenomeWeb
July 11, 2024
Genomic Testing Helps Personalize Care for Prostate Cancer Patients
Oncology Times
May 7, 2024
Veracyte Core Tests Maintain Growth as Firm Prepares to Shift Resources to Newest Acquisitions
GenomeWeb
February 27, 2024
Decipher Prostate test receives high evidence rating in NCCN guidelines
Urology Times
January 22, 2024
Noninvasive Testing Key to Id’ing Lung Cancer
Clinical Lab Products (CLP)